Products
SentimenTrader Trading Tools
‍
Backtest Engine
My Trading Toolkit
Correlation Analysis
Seasonality
Market Prediction
Indicators & Data API
‍
Proprietary Indicators & Charts
Market Data API
Strategies & Scanner
‍
50+ Trading Strategies
Smart Stock Scanner
Smart Option Scanner
Research Reports
‍
Research Solutions
Reports Library
Free Resources
Simple Backtest Calculator
Simple Seasonality Calculator
The Kelly Criterion Calculator
Sentiment Geo Map
Public Research Reports
Education
Sentiment Indicators
Technical Indicators
Pricing
Company
About
In the News
Testimonials
Client Success Stories
Contact
Log inLoginSign up
< BACK TO ALL REPORTS

It's time to keep an eye on healthcare

Jay Kaeppel
2025-04-23
A great deal of "weight of the evidence" is piling up on the favorable side of the ledger for the health care sector. In today's market environment, will it matter? We examine the prospects herein.

Key points

  • Many indicators are giving favorable signals for the healthcare sector
  • These individual signals do not constitute an outright buy signal, but serve rather as weight of the evidence
  • The "secret ingredient" for healthcare is the action of industry insiders

Sentiment flashes a green light for beaten-down healthcare

Over the long term, the healthcare sector has been a top - and relatively consistent - performer. However, the Health Care Sector SPDR Fund (ticker XLV) is essentially unchanged since August of 2021. The red line in the top clip of the chart below displays XLV price performance. The black line in the bottom clip displays XLV performance relative to the S&P 500. Note the sharp decline in relative performance from January 2023 to December 2024. Strong actual and relative performance by XLV has typically followed previous similar decreases.

Unsurprisingly, investor sentiment has become severely depressed in the healthcare sector. The chart below highlights all dates when the 3-day moving average for our XLV Optix indicator dropped below 5.5%.

The table below summarizes subsequent XLV performance.

The XLV Panic Breadth Composite indicator combines market sentiment and breadth analysis to identify investors' "hair on fire" behavior. The chart below highlights dates when the XLV Panic Breadth Composite crossed above 65 for the first time in three months, and the table summarizes subsequent XLV performance.

Speaking of breadth, the chart below highlights those dates when the XLV % Below BBand (i.e., the percentage of XLV constituent stocks that closed below their Bollinger Band) indicator crossed above 65%. This is typically indicative of a "washout." The table summarizes performance.

Let's consider one more breadth washout type of signal. The chart below highlights all dates when the XLV % RSI 14-Day < 30 (i.e., the percentage of XLV constituent stocks with a 14-day RSI of 30 or lower) indicator crossed above 56%. The table summarizes performance results.

New highs versus new lows also highlight an extreme condition

The XLV 12 Week Low % indicator shows the percentage of XLV constituent stocks currently trading at a 12-week low. The chart below highlights all dates when the indicator value crossed above 55. The table summarizes subsequent performance.

The chart below highlights all dates when the XLV Net New High-Low % indicator crossed below -35% (indicating a vast preponderance of sector stocks making new 52-week lows relative to those making new highs).

Insider buying is the "secret ingredient" for healthcare

Healthcare is not the only sector that is showing a lot of "favorable indicator signals" lately. However, insider buying is the one thing that it has witnessed that other sectors have not. Breadth and sentiment indicators can alert us that the selling in a given sector may be overdone. However, a significantly favorable relationship between insider buying and selling indicates that the people who know their companies' - and the industry as a whole - best are seeing value while others are panicking.

The chart below highlights all dates when our Corporate Insider Buy/Sell Ratio - XLV was above 0.12. The table summarizes XLV's performance.

While insiders are generally not "precision market timers," they are rarely wrong 1-3 years later. 

What the research tells us…

We cannot say that the healthcare sector is sure to advance in the year ahead, despite all of the "favorable indicator signals" highlighted above. We can say that a great deal of "weight of the evidence" is piling up on the favorable side of the ledger. We can also factor in that healthcare corporate insiders view the prospects for the shares of their company as attractive in the year ahead and possibly beyond. All of this strongly suggests that investors take a closer look - and keep a close eye on - the healthcare sector for a buying opportunity.

PRODUCTS
SentimenTrader
Trading Tools
Indicators & Data API
‍
Strategies & Scanner
‍
Research Reports
FREE
RESOUrCES
Simple Backtest
Calculator
Simple Seasonality
Calculator
The Kelly Criterion
Calculator
Sentiment Geo Map
‍
Public Research Reports
‍
Education
Sentiment Indicators
‍
Technical Indicators
‍
Pricing
Bundle pricing
‍
FAQ
‍
Announcements
‍
COMPANY
‍
About
‍
In the News
‍
Testimonials
‍
Client Success Stories
CONTACT
‍
General Inquiries
‍
Media Inquiries
‍
Financial Professionals Inquiries
‍
© 2026 Sundial Capital Research Inc. All rights reserved.
Setsail Marketing
TermsPrivacyAffiliate Program
Risk Disclosure: The information and tools provided are for research and analytical purposes only and are not intended as investment advice. Market analysis involves uncertainty, and outcomes may differ from expectations. Users should conduct their own due diligence and consider their individual circumstances before making any financial decisions. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure: Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all which can adversely affect trading results.

Testimonial Disclosure: Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.